..

Bronchial Associated Lymphoid Tissue Lymphoma in Systemic Lupus Erythematosus Successfully Treated with Rituximab

Abstract

Eid AlQurashi, Shikha Mittoo, Zahi Touma, Shane Shapera, Theodore K Marras and Muhammad Sohail Anjum

We present, for the first time to our knowledge, a patient with Systemic Lupus Erythematosus (SLE) with pulmonary Bronchial-Associated Lymphoid Tissue (BALT) lymphoma, refractory to chemotherapy but after a single four-week course of rituximab experienced significant regression of pulmonary lesions and remained progressionfree six months post- treatment. This case report demonstrates the promising role for rituximab in refractory BALT lymphoma.

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado

Comparte este artículo

Indexado en

arrow_upward arrow_upward